{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:07:44Z","timestamp":1791929264987,"version":"4.3.4"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Longer time between symptom onset and treatment of Lyme disease has been associated with poor outcomes. Reducing time-to-treatment requires knowledge of risks for treatment delays. We conducted a population-based study to evaluate factors associated with delayed treatment of Lyme disease and the relation between delayed treatment and post-treatment Lyme disease syndrome (PTLDS).<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We mailed questionnaires to 5,314 individuals with a Lyme disease diagnosis or blood test followed by an antibiotic order in the medical record of a Pennsylvania health system from 2015 to 2017. Analyses were confined to 778 respondents who reported that they were treated for Lyme disease within the past 5 years and reported a rash and\/or a positive blood test for Lyme disease. Time-to-treatment was calculated as the sum of two windows before and after seeking care for Lyme disease symptoms: time to first medical contact and time under care. We used logistic regression to evaluate factors associated with delayed time-to-treatment in each time window (&amp;gt;14 days vs. \u226414 days) and the association between total time-to-treatment (&amp;gt;30 days vs. \u226430 days) and PTLDS. We used inverse probability weighting to calculate estimates for the study's source population (5,314 individuals sent questionnaires).<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> In the source population, 25% had time to first contact &amp;gt;14 days, 21% had time under care &amp;gt;14 days, and 31% had a total time-to-treatment &amp;gt;30 days. Being uninsured and attributing initial symptoms to something other than Lyme disease were positively associated with delayed time to first medical contact, while seeking care at an urgent care or emergency setting (vs. primary care) was negatively associated. Diagnoses between November and April, and the absence of rash were positively associated with delays. Individuals whose treatment was delayed, defined as time-to treatment &amp;gt;30 days had 2.26 (95% confidence interval: 1.25, 4.05) times the odds of PTLDS as those who were treated within 30 days of symptom onset.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> In a population-based study in Pennsylvania, one-third of Lyme disease patients reported delayed treatment, which was associated with PTLDS. To improve Lyme disease outcomes, prevention efforts should aim to reduce the time before and after seeking care.<\/jats:p>","DOI":"10.3389\/fmed.2020.560018","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T07:25:54Z","timestamp":1606375554000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Risk Factors and Outcomes of Treatment Delays in Lyme Disease: A Population-Based Retrospective Cohort Study"],"prefix":"10.3389","volume":"7","author":[{"given":"Annemarie G.","family":"Hirsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa N.","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Nordberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison W.","family":"Rebman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Aucott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Heaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian S.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,26]]},"reference":[{"key":"B1","unstructured":"Climate Change Increases the Number and Geographic Range of Disease-Carrying Insects and Ticks2019"},{"key":"B2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.idc.2015.02.010","article-title":"Epidemiology of lyme disease","volume":"29","author":"Mead","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"B3","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the infectious diseases society of America","volume":"45","author":"Wormser","year":"2007","journal-title":"Clin Infect Dis"},{"key":"B4","unstructured":"Characteristics and clinical outcome of Lyme neuroborreliosis in a high endemic area, 1995\u20132014: a retrospective cohort study in Denmark148995\n            KnudtzenFC\n            AndersonNS\n            JensenTG\n            SkarphedinssonS\n          10.1093\/cid\/cix56829048514Clin Infect Dis.652017"},{"key":"B5","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1468-1331.2009.02756.x","article-title":"Remaining complaints 1 year after treatment for acute lyme neuroborrelisos; frequency, pattern, and risk factors","volume":"17","author":"Lj\u00f8stad","year":"2010","journal-title":"Eur J Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.7326\/0003-4819-131-12-199912210-00003","article-title":"Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease","volume":"131","author":"Shadik","year":"1999","journal-title":"Ann Intern Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1600-0404.2012.01690.x","article-title":"Risk factors for a non-favorable outcome after treated European neuroborreliosis","volume":"127","author":"Eikeland","year":"2013","journal-title":"Acta Neurol Scandinavica"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e443","DOI":"10.1016\/j.ijid.2013.01.008","article-title":"Development of a foundation for a case definition of post-treatment lyme disease syndrome","volume":"17","author":"Aucott","year":"2013","journal-title":"Int J Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nrneurol.2015.121","article-title":"Lyme neuroborreliosis-epidemiology, diagnosis and management","volume":"11","author":"Koedel","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.idc.2007.12.011","article-title":"Chronic lyme disease: a review","volume":"22","author":"Marques","year":"2008","journal-title":"Infect Dis Clin North Am"},{"key":"B11","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3389\/fmed.2017.00224","article-title":"The clinical, symptom and quality-of-life characterization of a well-defined group of patients with posttreatment lyme disease syndrome","volume":"4","author":"Rebman","year":"2017","journal-title":"Front Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.2044-8309.1995.tb01047.x","article-title":"Delay in seeking a cancer diagnosis: delay stages and psychophysiological comparison processes","volume":"34","author":"Andersen","year":"1995","journal-title":"Br J Soc Psychol"},{"key":"B13","unstructured":"Lyme Disease Data Tables: Most Recent Year. 20182018"},{"key":"B14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/EDE.0000000000000387","article-title":"Unconventional natural gas development and birth outcomes in Pennsylvania, USA","volume":"27","author":"Casey","year":"2016","journal-title":"Epidemiology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ttbdis.2018.10.010","article-title":"Epidemiology of lyme disease in Pennsylvania 2006-2014 using electronic health records","volume":"10","author":"Moon","year":"2018","journal-title":"Tick Tick Borne Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e021367","DOI":"10.1136\/bmjopen-2017-021367","article-title":"Obstacles to diagnosis and treatment of lyme disease in the USA: a qualitative study","volume":"8","author":"Hirsch","year":"2018","journal-title":"BMJ Open."},{"key":"B17","unstructured":"36-Item Short Form Survey (SF-36)2019"},{"key":"B18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-2458-8-41","article-title":"The influence of active coping and perceived stress on health disparities in a multi-ethnic low income sample","volume":"8","author":"Watson","year":"2008","journal-title":"BMC Public Health."},{"key":"B19","volume-title":"Stata Statistical Software: Release 14","year":"2015"},{"key":"B20","doi-asserted-by":"publisher","first-page":"560","DOI":"10.7326\/0003-4819-121-8-199410150-00002","article-title":"The long-term clinical outcomes of lyme disease: a population-based retrospective cohort study","volume":"121","author":"Shadik","year":"1994","journal-title":"Ann Intern Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1001\/jama.297.23.2617","article-title":"Does this patient have erythema migrans?","volume":"297","author":"Tibbles","year":"2007","journal-title":"JAMA."},{"key":"B22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1471-2334-9-79","article-title":"Diagnostic challenges of early Lyme disease: lessons from a community case series","volume":"9","author":"Aucott","year":"2009","journal-title":"BMC Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1161\/CIRCOUTCOMES.109.884361","article-title":"Age and sex differences in duration of prehospital delay in patients with acute myocardial infarction: a systematic review","volume":"3","author":"Nguyen","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1001\/jama.2010.409","article-title":"Health care insurance, financial concerns in accessing care, and delays to hospital presentation in acute myocardial infarction","volume":"303","author":"Smolderen","year":"2010","journal-title":"JAMA"},{"key":"B25","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1158\/1055-9965.EPI-09-0997","article-title":"Misconceptions about breast lumps and delayed medical presentation in urban breast cancer patients","volume":"19","author":"Rauscher","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0116767","DOI":"10.1371\/journal.pone.0116767","article-title":"Health care costs, utilization and patterns of care following Lyme disease","author":"Adrion","year":"2015","journal-title":"PLoS ONE."},{"key":"B27","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1177\/1062860609353201","article-title":"Why do patients seek care at retail clinics and what alternatives did they consider?","volume":"25","author":"Wang","year":"2010","journal-title":"Am J Med Qual"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1001\/jama.1993.03500140064037","article-title":"The overdiagnosis of lyme disease","volume":"269","author":"Steere","year":"1993","journal-title":"JAMA"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.560018\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T07:26:02Z","timestamp":1606375562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.560018\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,26]]},"references-count":28,"alternative-id":["10.3389\/fmed.2020.560018"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.560018","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,26]]},"article-number":"560018"}}